0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Tropicamide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-16L8313
Home | Market Reports | Health| Pharmacy
Global Tropicamide Market Insights Forecast to 2028
BUY CHAPTERS

Tropicamide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-16L8313
Report
November 2024
Pages:166
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tropicamide - Market Size

The global market for Tropicamide was estimated to be worth US$ 3612 million in 2023 and is forecast to a readjusted size of US$ 4905.6 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030

Tropicamide - Market

Tropicamide - Market

Tropicamide, sold under the brand name Mydriacyl among others, is a medication used to dilate the pupil and help with examination of the eye. Specifically it is used to help examine the back of the eye. It is applied as eye drops. Effects occur within 40 minutes and last for up to a day.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tropicamide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tropicamide by region & country, by Type, and by Application.
The Tropicamide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tropicamide.
Market Segmentation

Scope of Tropicamide - Market Report

Report Metric Details
Report Name Tropicamide - Market
Forecasted market size in 2030 US$ 4905.6 million
CAGR 4.5%
Forecasted years 2024 - 2030
Segment by Type:
  • 5mg
  • 10mg
Segment by Application
  • Hospital
  • Drug Store
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alcon Laboratories, Akorn, Bausch Health, Miza Pharmaceuticals, Watson Laboratories, Novartis, Dioptic Pharmaceuticals, Roemmers, Thea Pharma, Vega Pharma, Agepha Pharma, Pharma Stulln, Visufarma, Unimed Pharma, Edol, Polfa Warszawa, Laboratorios Sophia, Nippon Tenganyaku Kenkyujo, Wakamoto, Chauvin Ankerpharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Tropicamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Tropicamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Tropicamide in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Tropicamide - Market size in 2030?

Ans: The Tropicamide - Market size in 2030 will be US$ 4905.6 million.

Who are the main players in the Tropicamide - Market report?

Ans: The main players in the Tropicamide - Market are Alcon Laboratories, Akorn, Bausch Health, Miza Pharmaceuticals, Watson Laboratories, Novartis, Dioptic Pharmaceuticals, Roemmers, Thea Pharma, Vega Pharma, Agepha Pharma, Pharma Stulln, Visufarma, Unimed Pharma, Edol, Polfa Warszawa, Laboratorios Sophia, Nippon Tenganyaku Kenkyujo, Wakamoto, Chauvin Ankerpharm

What are the Application segmentation covered in the Tropicamide - Market report?

Ans: The Applications covered in the Tropicamide - Market report are Hospital, Drug Store

What are the Type segmentation covered in the Tropicamide - Market report?

Ans: The Types covered in the Tropicamide - Market report are 5mg, 10mg

1 Market Overview
1.1 Tropicamide Product Introduction
1.2 Global Tropicamide Market Size Forecast
1.2.1 Global Tropicamide Sales Value (2019-2030)
1.2.2 Global Tropicamide Sales Volume (2019-2030)
1.2.3 Global Tropicamide Sales Price (2019-2030)
1.3 Tropicamide Market Trends & Drivers
1.3.1 Tropicamide Industry Trends
1.3.2 Tropicamide Market Drivers & Opportunity
1.3.3 Tropicamide Market Challenges
1.3.4 Tropicamide Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tropicamide Players Revenue Ranking (2023)
2.2 Global Tropicamide Revenue by Company (2019-2024)
2.3 Global Tropicamide Players Sales Volume Ranking (2023)
2.4 Global Tropicamide Sales Volume by Company Players (2019-2024)
2.5 Global Tropicamide Average Price by Company (2019-2024)
2.6 Key Manufacturers Tropicamide Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Tropicamide Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Tropicamide
2.9 Tropicamide Market Competitive Analysis
2.9.1 Tropicamide Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Tropicamide Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tropicamide as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 5mg
3.1.2 10mg
3.2 Global Tropicamide Sales Value by Type
3.2.1 Global Tropicamide Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Tropicamide Sales Value, by Type (2019-2030)
3.2.3 Global Tropicamide Sales Value, by Type (%) (2019-2030)
3.3 Global Tropicamide Sales Volume by Type
3.3.1 Global Tropicamide Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Tropicamide Sales Volume, by Type (2019-2030)
3.3.3 Global Tropicamide Sales Volume, by Type (%) (2019-2030)
3.4 Global Tropicamide Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Tropicamide Sales Value by Application
4.2.1 Global Tropicamide Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Tropicamide Sales Value, by Application (2019-2030)
4.2.3 Global Tropicamide Sales Value, by Application (%) (2019-2030)
4.3 Global Tropicamide Sales Volume by Application
4.3.1 Global Tropicamide Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Tropicamide Sales Volume, by Application (2019-2030)
4.3.3 Global Tropicamide Sales Volume, by Application (%) (2019-2030)
4.4 Global Tropicamide Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Tropicamide Sales Value by Region
5.1.1 Global Tropicamide Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Tropicamide Sales Value by Region (2019-2024)
5.1.3 Global Tropicamide Sales Value by Region (2025-2030)
5.1.4 Global Tropicamide Sales Value by Region (%), (2019-2030)
5.2 Global Tropicamide Sales Volume by Region
5.2.1 Global Tropicamide Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Tropicamide Sales Volume by Region (2019-2024)
5.2.3 Global Tropicamide Sales Volume by Region (2025-2030)
5.2.4 Global Tropicamide Sales Volume by Region (%), (2019-2030)
5.3 Global Tropicamide Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Tropicamide Sales Value, 2019-2030
5.4.2 North America Tropicamide Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Tropicamide Sales Value, 2019-2030
5.5.2 Europe Tropicamide Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Tropicamide Sales Value, 2019-2030
5.6.2 Asia Pacific Tropicamide Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Tropicamide Sales Value, 2019-2030
5.7.2 South America Tropicamide Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Tropicamide Sales Value, 2019-2030
5.8.2 Middle East & Africa Tropicamide Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tropicamide Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Tropicamide Sales Value
6.2.1 Key Countries/Regions Tropicamide Sales Value, 2019-2030
6.2.2 Key Countries/Regions Tropicamide Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Tropicamide Sales Value, 2019-2030
6.3.2 United States Tropicamide Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Tropicamide Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tropicamide Sales Value, 2019-2030
6.4.2 Europe Tropicamide Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Tropicamide Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Tropicamide Sales Value, 2019-2030
6.5.2 China Tropicamide Sales Value by Type (%), 2023 VS 2030
6.5.3 China Tropicamide Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Tropicamide Sales Value, 2019-2030
6.6.2 Japan Tropicamide Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Tropicamide Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Tropicamide Sales Value, 2019-2030
6.7.2 South Korea Tropicamide Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Tropicamide Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Tropicamide Sales Value, 2019-2030
6.8.2 Southeast Asia Tropicamide Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Tropicamide Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Tropicamide Sales Value, 2019-2030
6.9.2 India Tropicamide Sales Value by Type (%), 2023 VS 2030
6.9.3 India Tropicamide Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Alcon Laboratories
7.1.1 Alcon Laboratories Company Information
7.1.2 Alcon Laboratories Introduction and Business Overview
7.1.3 Alcon Laboratories Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Alcon Laboratories Tropicamide Product Offerings
7.1.5 Alcon Laboratories Recent Development
7.2 Akorn
7.2.1 Akorn Company Information
7.2.2 Akorn Introduction and Business Overview
7.2.3 Akorn Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Akorn Tropicamide Product Offerings
7.2.5 Akorn Recent Development
7.3 Bausch Health
7.3.1 Bausch Health Company Information
7.3.2 Bausch Health Introduction and Business Overview
7.3.3 Bausch Health Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bausch Health Tropicamide Product Offerings
7.3.5 Bausch Health Recent Development
7.4 Miza Pharmaceuticals
7.4.1 Miza Pharmaceuticals Company Information
7.4.2 Miza Pharmaceuticals Introduction and Business Overview
7.4.3 Miza Pharmaceuticals Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Miza Pharmaceuticals Tropicamide Product Offerings
7.4.5 Miza Pharmaceuticals Recent Development
7.5 Watson Laboratories
7.5.1 Watson Laboratories Company Information
7.5.2 Watson Laboratories Introduction and Business Overview
7.5.3 Watson Laboratories Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Watson Laboratories Tropicamide Product Offerings
7.5.5 Watson Laboratories Recent Development
7.6 Novartis
7.6.1 Novartis Company Information
7.6.2 Novartis Introduction and Business Overview
7.6.3 Novartis Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Novartis Tropicamide Product Offerings
7.6.5 Novartis Recent Development
7.7 Dioptic Pharmaceuticals
7.7.1 Dioptic Pharmaceuticals Company Information
7.7.2 Dioptic Pharmaceuticals Introduction and Business Overview
7.7.3 Dioptic Pharmaceuticals Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Dioptic Pharmaceuticals Tropicamide Product Offerings
7.7.5 Dioptic Pharmaceuticals Recent Development
7.8 Roemmers
7.8.1 Roemmers Company Information
7.8.2 Roemmers Introduction and Business Overview
7.8.3 Roemmers Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Roemmers Tropicamide Product Offerings
7.8.5 Roemmers Recent Development
7.9 Thea Pharma
7.9.1 Thea Pharma Company Information
7.9.2 Thea Pharma Introduction and Business Overview
7.9.3 Thea Pharma Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Thea Pharma Tropicamide Product Offerings
7.9.5 Thea Pharma Recent Development
7.10 Vega Pharma
7.10.1 Vega Pharma Company Information
7.10.2 Vega Pharma Introduction and Business Overview
7.10.3 Vega Pharma Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Vega Pharma Tropicamide Product Offerings
7.10.5 Vega Pharma Recent Development
7.11 Agepha Pharma
7.11.1 Agepha Pharma Company Information
7.11.2 Agepha Pharma Introduction and Business Overview
7.11.3 Agepha Pharma Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Agepha Pharma Tropicamide Product Offerings
7.11.5 Agepha Pharma Recent Development
7.12 Pharma Stulln
7.12.1 Pharma Stulln Company Information
7.12.2 Pharma Stulln Introduction and Business Overview
7.12.3 Pharma Stulln Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Pharma Stulln Tropicamide Product Offerings
7.12.5 Pharma Stulln Recent Development
7.13 Visufarma
7.13.1 Visufarma Company Information
7.13.2 Visufarma Introduction and Business Overview
7.13.3 Visufarma Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Visufarma Tropicamide Product Offerings
7.13.5 Visufarma Recent Development
7.14 Unimed Pharma
7.14.1 Unimed Pharma Company Information
7.14.2 Unimed Pharma Introduction and Business Overview
7.14.3 Unimed Pharma Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Unimed Pharma Tropicamide Product Offerings
7.14.5 Unimed Pharma Recent Development
7.15 Edol
7.15.1 Edol Company Information
7.15.2 Edol Introduction and Business Overview
7.15.3 Edol Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Edol Tropicamide Product Offerings
7.15.5 Edol Recent Development
7.16 Polfa Warszawa
7.16.1 Polfa Warszawa Company Information
7.16.2 Polfa Warszawa Introduction and Business Overview
7.16.3 Polfa Warszawa Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Polfa Warszawa Tropicamide Product Offerings
7.16.5 Polfa Warszawa Recent Development
7.17 Laboratorios Sophia
7.17.1 Laboratorios Sophia Company Information
7.17.2 Laboratorios Sophia Introduction and Business Overview
7.17.3 Laboratorios Sophia Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Laboratorios Sophia Tropicamide Product Offerings
7.17.5 Laboratorios Sophia Recent Development
7.18 Nippon Tenganyaku Kenkyujo
7.18.1 Nippon Tenganyaku Kenkyujo Company Information
7.18.2 Nippon Tenganyaku Kenkyujo Introduction and Business Overview
7.18.3 Nippon Tenganyaku Kenkyujo Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Nippon Tenganyaku Kenkyujo Tropicamide Product Offerings
7.18.5 Nippon Tenganyaku Kenkyujo Recent Development
7.19 Wakamoto
7.19.1 Wakamoto Company Information
7.19.2 Wakamoto Introduction and Business Overview
7.19.3 Wakamoto Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Wakamoto Tropicamide Product Offerings
7.19.5 Wakamoto Recent Development
7.20 Chauvin Ankerpharm
7.20.1 Chauvin Ankerpharm Company Information
7.20.2 Chauvin Ankerpharm Introduction and Business Overview
7.20.3 Chauvin Ankerpharm Tropicamide Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Chauvin Ankerpharm Tropicamide Product Offerings
7.20.5 Chauvin Ankerpharm Recent Development
8 Industry Chain Analysis
8.1 Tropicamide Industrial Chain
8.2 Tropicamide Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tropicamide Sales Model
8.5.2 Sales Channel
8.5.3 Tropicamide Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Tropicamide Market Trends
    Table 2. Tropicamide Market Drivers & Opportunity
    Table 3. Tropicamide Market Challenges
    Table 4. Tropicamide Market Restraints
    Table 5. Global Tropicamide Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Tropicamide Revenue Market Share by Company (2019-2024)
    Table 7. Global Tropicamide Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Tropicamide Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Tropicamide Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Tropicamide Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Tropicamide Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Tropicamide
    Table 13. Global Tropicamide Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tropicamide as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Tropicamide Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Tropicamide Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Tropicamide Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Tropicamide Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Tropicamide Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Tropicamide Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Tropicamide Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Tropicamide Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Tropicamide Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Tropicamide Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Tropicamide Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Tropicamide Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Tropicamide Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Tropicamide Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Tropicamide Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Tropicamide Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Tropicamide Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Tropicamide Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Tropicamide Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Tropicamide Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Tropicamide Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Tropicamide Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Tropicamide Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Tropicamide Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Tropicamide Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Tropicamide Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Tropicamide Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Tropicamide Sales Value by Region (2019-2024) & (%)
    Table 44. Global Tropicamide Sales Value by Region (2025-2030) & (%)
    Table 45. Global Tropicamide Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Tropicamide Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Tropicamide Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Tropicamide Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Tropicamide Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Tropicamide Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Tropicamide Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Tropicamide Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Tropicamide Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Tropicamide Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Tropicamide Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Tropicamide Sales Volume, (2025-2030) & (K Units)
    Table 57. Alcon Laboratories Company Information
    Table 58. Alcon Laboratories Introduction and Business Overview
    Table 59. Alcon Laboratories Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Alcon Laboratories Tropicamide Product Offerings
    Table 61. Alcon Laboratories Recent Development
    Table 62. Akorn Company Information
    Table 63. Akorn Introduction and Business Overview
    Table 64. Akorn Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Akorn Tropicamide Product Offerings
    Table 66. Akorn Recent Development
    Table 67. Bausch Health Company Information
    Table 68. Bausch Health Introduction and Business Overview
    Table 69. Bausch Health Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Bausch Health Tropicamide Product Offerings
    Table 71. Bausch Health Recent Development
    Table 72. Miza Pharmaceuticals Company Information
    Table 73. Miza Pharmaceuticals Introduction and Business Overview
    Table 74. Miza Pharmaceuticals Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Miza Pharmaceuticals Tropicamide Product Offerings
    Table 76. Miza Pharmaceuticals Recent Development
    Table 77. Watson Laboratories Company Information
    Table 78. Watson Laboratories Introduction and Business Overview
    Table 79. Watson Laboratories Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Watson Laboratories Tropicamide Product Offerings
    Table 81. Watson Laboratories Recent Development
    Table 82. Novartis Company Information
    Table 83. Novartis Introduction and Business Overview
    Table 84. Novartis Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Novartis Tropicamide Product Offerings
    Table 86. Novartis Recent Development
    Table 87. Dioptic Pharmaceuticals Company Information
    Table 88. Dioptic Pharmaceuticals Introduction and Business Overview
    Table 89. Dioptic Pharmaceuticals Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Dioptic Pharmaceuticals Tropicamide Product Offerings
    Table 91. Dioptic Pharmaceuticals Recent Development
    Table 92. Roemmers Company Information
    Table 93. Roemmers Introduction and Business Overview
    Table 94. Roemmers Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Roemmers Tropicamide Product Offerings
    Table 96. Roemmers Recent Development
    Table 97. Thea Pharma Company Information
    Table 98. Thea Pharma Introduction and Business Overview
    Table 99. Thea Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Thea Pharma Tropicamide Product Offerings
    Table 101. Thea Pharma Recent Development
    Table 102. Vega Pharma Company Information
    Table 103. Vega Pharma Introduction and Business Overview
    Table 104. Vega Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Vega Pharma Tropicamide Product Offerings
    Table 106. Vega Pharma Recent Development
    Table 107. Agepha Pharma Company Information
    Table 108. Agepha Pharma Introduction and Business Overview
    Table 109. Agepha Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Agepha Pharma Tropicamide Product Offerings
    Table 111. Agepha Pharma Recent Development
    Table 112. Pharma Stulln Company Information
    Table 113. Pharma Stulln Introduction and Business Overview
    Table 114. Pharma Stulln Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Pharma Stulln Tropicamide Product Offerings
    Table 116. Pharma Stulln Recent Development
    Table 117. Visufarma Company Information
    Table 118. Visufarma Introduction and Business Overview
    Table 119. Visufarma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Visufarma Tropicamide Product Offerings
    Table 121. Visufarma Recent Development
    Table 122. Unimed Pharma Company Information
    Table 123. Unimed Pharma Introduction and Business Overview
    Table 124. Unimed Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Unimed Pharma Tropicamide Product Offerings
    Table 126. Unimed Pharma Recent Development
    Table 127. Edol Company Information
    Table 128. Edol Introduction and Business Overview
    Table 129. Edol Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Edol Tropicamide Product Offerings
    Table 131. Edol Recent Development
    Table 132. Polfa Warszawa Company Information
    Table 133. Polfa Warszawa Introduction and Business Overview
    Table 134. Polfa Warszawa Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Polfa Warszawa Tropicamide Product Offerings
    Table 136. Polfa Warszawa Recent Development
    Table 137. Laboratorios Sophia Company Information
    Table 138. Laboratorios Sophia Introduction and Business Overview
    Table 139. Laboratorios Sophia Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Laboratorios Sophia Tropicamide Product Offerings
    Table 141. Laboratorios Sophia Recent Development
    Table 142. Nippon Tenganyaku Kenkyujo Company Information
    Table 143. Nippon Tenganyaku Kenkyujo Introduction and Business Overview
    Table 144. Nippon Tenganyaku Kenkyujo Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Nippon Tenganyaku Kenkyujo Tropicamide Product Offerings
    Table 146. Nippon Tenganyaku Kenkyujo Recent Development
    Table 147. Wakamoto Company Information
    Table 148. Wakamoto Introduction and Business Overview
    Table 149. Wakamoto Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Wakamoto Tropicamide Product Offerings
    Table 151. Wakamoto Recent Development
    Table 152. Chauvin Ankerpharm Company Information
    Table 153. Chauvin Ankerpharm Introduction and Business Overview
    Table 154. Chauvin Ankerpharm Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Chauvin Ankerpharm Tropicamide Product Offerings
    Table 156. Chauvin Ankerpharm Recent Development
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Tropicamide Downstream Customers
    Table 160. Tropicamide Distributors List
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tropicamide Product Picture
    Figure 2. Global Tropicamide Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Tropicamide Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Tropicamide Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Tropicamide Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Tropicamide Report Years Considered
    Figure 7. Global Tropicamide Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Tropicamide Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tropicamide Revenue in 2023
    Figure 10. Tropicamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 5mg Picture
    Figure 12. 10mg Picture
    Figure 13. Global Tropicamide Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Tropicamide Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Tropicamide Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Tropicamide Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Tropicamide Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Drug Store
    Figure 20. Global Tropicamide Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Tropicamide Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Tropicamide Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Tropicamide Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Tropicamide Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America Tropicamide Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Tropicamide Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Tropicamide Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Tropicamide Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Tropicamide Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Tropicamide Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Tropicamide Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Tropicamide Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Tropicamide Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Tropicamide Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Tropicamide Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Tropicamide Sales Volume (%), (2019-2030)
    Figure 37. United States Tropicamide Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Tropicamide Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Tropicamide Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Tropicamide Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Tropicamide Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Tropicamide Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Tropicamide Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Tropicamide Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Tropicamide Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Tropicamide Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Tropicamide Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Tropicamide Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Tropicamide Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Tropicamide Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Tropicamide Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Tropicamide Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Tropicamide Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Tropicamide Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Tropicamide Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Tropicamide Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Tropicamide Sales Value by Application (%), 2023 VS 2030
    Figure 58. Tropicamide Industrial Chain
    Figure 59. Tropicamide Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35Z18485
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28M18423
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Compound Antibacterial Agent for Animal - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38V14855
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Antipyretic Stickers Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-22E8302
Thu Dec 12 00:00:00 UTC 2024

Add to Cart